Form 4: ITRON SVP Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Itron's SVP of Outcomes, Donald L. Reeves III, sold 1,055 shares of common stock for $96.25 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Donald L. Reeves III, SVP of Outcomes at Itron, Inc. (ITRI), reported a sale of common stock.
- The transaction involved the disposition of 1,055 shares of Itron common stock.
- The shares were sold at a price of $96.25 per share.
- Following this transaction, Mr. Reeves beneficially owns 31,014 shares directly.
- The sale was executed on February 23, 2026, under a Rule 10b5-1 trading plan adopted on September 11, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While an insider sale, its execution under a pre-established 10b5-1 plan suggests a planned diversification rather than a reaction to new negative company-specific news.
Negatives
- An insider sale of 1,055 shares by a Senior Vice President, which, while under a 10b5-1 plan, reduces management's direct equity stake.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for insights into management's perception of future company performance. Sales under 10b5-1 plans are common for executives to manage personal finances and diversify holdings while avoiding accusations of trading on material non-public information.
Related Party Transactions
- Sale of 1,055 shares of Itron common stock by SVP Donald L. Reeves III at $96.25 per share.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, potentially viewed with slight caution, though mitigated by the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 09/11/2025 | Date Rule 10b5-1 Trading Plan was adopted by Mr. Reeves. |
| 02/23/2026 | Date of common stock transaction (sale). |
| 02/25/2026 | Date the Form 4 was signed. |
Recommendation
holdThe sale by SVP Donald L. Reeves III was conducted under a Rule 10b5-1 trading plan, indicating it was a pre-scheduled transaction for personal financial management rather than a signal of a change in company fundamentals. This type of routine insider transaction does not typically warrant a change in investment recommendation.
Keywords
Itron, ITRI, Insider Trading, Form 4, Stock Sale, Donald L. Reeves III, 10b5-1 Plan, Officer Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.